Dmitry Balyasny’s Neuronetics STIM Stock Holding History

Dmitry Balyasny’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-713,300	Closed	-$984K	–	3495
2025 Q4	$984K	Sell	713,300 -566,200	-44%	-$1.18M	﹤0.01%	2208
2025 Q3	$3.49M	Buy	+1,279,500	New	+$4.55M	﹤0.01%	1548

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dmitry Balyasny's STIM Position: Q2 2026 in Review

Dmitry Balyasny sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 2,743,768 shares — an estimated $3.98M sold.

Dmitry Balyasny first reported a position in STIM in Q1 2023 and held it in 13 quarters. The position peaked at $5.57M in Q1 2024. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

Dmitry Balyasny reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 2,743,768 Neuronetics shares in Q2 2026, an estimated $3.98M.
Dmitry Balyasny first reported a position in Neuronetics in Q1 2023 and held it in 13 quarters.
Dmitry Balyasny's Neuronetics position peaked at $5.57M in Q1 2024.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.